Enzymes catalyze chemical reactions in organisms—without which life would not be possible. Leveraging AlphaFold2 artificial ...

Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...

Candida, a type of fungus, can spread throughout the body via the bloodstream, leading to organ damage and sepsis. Recently, ...

Discover 5 dangerous drug-resistant fungi posing epidemic threats. Learn how these deadly superbugs are spreading and what ...

In 2020, 20 large drugmakers founded the AMR Action Fund to boost the pipeline of antifungal and antibiotic drugs, with a target of enabling as much as four novel antibiotics to hit the market by ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Enter a new antifungal, mandimycin. It’s the latest addition to a group of antifungals called glycosylated polyene macrolides, but it works differently from the rest.

The discovery of a new preclinical compound with strong antifungal activity against multidrug-resistant pathogens is ...

Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Mathur, Neha. (2023, July 19). Understanding the mechanisms behind rising antifungal drug resistance.

A newly discovered bacterial weapon against fungi can kill even drug-resistant strains, raising hopes for a new antifungal drug. Bacteria are masters at fending off fungi, says Martin Burke, a ...

Rex’s company, F2G, is in the final stages of clinical trials for an antifungal drug called olorofim. This drug prevents fungi from making pyrimidines, a type of building block for DNA and RNA.